BETA-catenin市場：按類型、應用和地區分類

預計到 2026 年，BETA-catenin 市值將達到 35.94 億美元，到 2033 年將達到 68.22 億美元。預計從 2026 年到 2033 年，其複合年成長率將達到 11.2%。

BETA-連環蛋白對胚胎生長發育至關重要。人類CTNNB1基因編碼BETA-連環蛋白。此蛋白具有兩種功能，也稱為BETA-連環蛋白-1，參與細胞調控、基因轉錄和細胞黏附。此外，該蛋白促進細胞黏附，這對骨骼和皮膚等結構的形成至關重要。細胞內基因的活性受某些BETA-連環蛋白的調控。 BETA-連環蛋白透過與稱為轉錄因子的特定分子結合發揮作用，轉錄因子與去氧核糖核酸（DNA）結合，影響胚胎發育為完整人體的過程。此外，BETA-連環蛋白也調控細胞分裂和增生。 BETA-連環蛋白是細胞核內經典Wnt訊號路徑的關鍵核效應分子，也是鈣黏蛋白介導的黏附連接的結構成分。 BETA-連環蛋白的結構和訊號失衡通常會導致與轉移和癌症相關的疾病，以及增殖功能障礙。經典 Wnt 級聯反應的主要效應因子是 BETA-catenin，它將訊號傳遞到細胞核，並觸發 Wnt特異性基因的轉錄，這些基因調節各種細胞和器官的細胞命運決定。

市場動態

預計在預測期內，市場上的主要企業將推動市場成長，而癌症患者數量的不斷增加是主要驅動力。例如，根據美國癌症協會2022年1月發布的數據，2022年美國約有106,180例大腸癌病例。此外，根據世界衛生組織（WHO）2021年3月發布的數據，2020年全球有230萬名女性被診斷出罹患乳癌，其中68.5萬人死於乳癌。

本報告的主要特點

• 本報告對全球BETA-catenin市場進行了詳細分析，包括預測期（2026-2033年）的市場規模和複合年成長率，以2025年為基準年。
• 此外，它還確定了每個細分市場的潛在商機，並描述了該市場中一系列有吸引力的投資提案。
• 此外，它還提供了有關市場促進因素和限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要企業採取的競爭策略的重要見解。
• 本節根據以下參數介紹全球BETA-catenin市場的主要企業概況：公司概況、產品系列、主要亮點、財務績效和策略。
• 本報告中的見解將使負責人和企業經營團隊能夠就未來的產品發布、產品線更新、市場擴張和行銷策略做出明智的決策。
• 《全球BETA-連環蛋白市場》報告面向該行業的眾多相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
• 相關人員可以透過分析全球BETA-catenin市場中使用的各種策略矩陣來促進決策。

目錄

第1章：分析目標與假設

• 分析目的
• 先決條件
• 簡稱

第2章 市場展望

• 報告說明
  • 市場定義和範圍
• 執行摘要
• Coherent Opportunity Map（COM）

第3章：市場動態、監管與趨勢分析

• 市場動態
  • 促進因素
  • 阻礙因素
  • 市場機遇
• 影響分析
• 市場趨勢
• 主要進展
• 產品核准
• 商業夥伴關係、企業合併與收購 (M&A)
• 監理情勢
• PEST分析
• 波特五力分析
• 流行病學
• 固體管道分析

第4章：全球BETA-連環蛋白市場：依類型分類（2026-2033年）

• BBI-801
• 埃克塞林德
• M-101
• 鹽酸奈福泮
• 其他

第5章：全球BETA-連環蛋白市場：依應用領域分類（2026-2033年）

• 皮膚病
• 瘤
• 遺傳性疾病
• 其他

第6章 全球BETA-連環蛋白市場：依地區分類（2026-2033年）

• 北美洲
  • 美國
  • 加拿大
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲
• 歐洲
  • 英國
  • 德國
  • 義大利
  • 法國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • ASEAN
  • 澳洲
  • 韓國
  • 其他亞太地區
• 中東
  • 波灣合作理事會（GCC）國家
  • 以色列
  • 其他中東國家
• 非洲
  • 北非
  • 中非
  • 南非

第7章 競爭情勢

• 熱圖分析
• 市佔率分析
• 公司簡介
  • Boston Biomedical Inc
  • Dicerna Pharmaceuticals Inc.
  • Marina Biotech Inc.
  • Propanac Biopharma Inc
  • Warp Drive Bio Inc.
  • prism pharma co ltd
  • aileron therapeutics inc
  • MD2 Biosciences Inc
  • WntRx Pharmaceuticals Inc
  • Sapience Therapeutics Inc
  • Venn Therapeutics LLC

第8章

• 參考
• 分析方法
• 關於 Coherent Market Insights

Beta Catenin Market is estimated to be valued at USD 3,594 Mn in 2026 and is expected to reach USD 6,822 Mn by 2033, growing at a compound annual growth rate (CAGR) of 11.2% from 2026 to 2033.

A protein called beta-catenin is crucial for growth and development of embryos. The CTNNB1 gene in humans encodes the protein catenin beta. It is a protein with two functions that is also known as beta-catenin 1 and is involved in the control and coordination of cells, gene transcription, and cell adhesion. Additionally, it promotes cell adhesion, which is essential for the development of structures like bones and skin. The activity of genes in cells is regulated in part by beta-catenin. It functions by attaching to certain molecules known as transcription factors, which bind to Deoxyribonucleic acid (DNA) and influence how an embryo grows into a fully formed human being. Additionally, beta catenin regulates cell division and growth (proliferation). B-catenin is a crucial nuclear effector of canonical Wntsignaling in the nucleus and a structural component of cadherin-based adherens junctions. B-catenin structural and signaling imbalance frequently causes sickness and dysfunctional growth linked to metastasis and cancer. The primary effector in the canonical Wnt cascade is B-catenin, which transmits the signal to the nucleus and causes transcription of Wnt-specific genes that regulate cell fate decisions in a variety of cells and organs.

Market Dynamics

Key players operating in market are expected to drive the market growth during the forecast period, owing to increase in cancer patients. For instance, according to data published in January 2022, by the American Cancer Society, in 2022 in the U.S., there are about 106,180 cases of colon cancer. Moreover, according to data published on March 2021, by World Health Organization, states that, in 2020, there were 2.3 million women diagnosed with breast cancer globally and 685 000 deaths globally.

Key features of the study

• This report provides in-depth analysis of the global beta catenin market , and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period (2026-2033), considering 2025 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global beta catenin market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Boston Biomedical Inc, Dicerna Pharmaceuticals Inc., Marina Biotech Inc., Propanac Biopharma Inc, Warp Drive Bio Inc., prism pharma co ltd, , aileron therapeutics inc, MD2 Biosciences Inc, WntRx Pharmaceuticals Inc, Sapience Therapeutics Inc, and Venn Therapeutics LLC
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global beta catenin market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global beta catenin market

Market Segmentation

• By Type
  • BBI-801,
  • Exisulind
  • M-101
  • Nefopam Hydrochloride
  • Others
• By Application
  • Dermatology
  • Oncology
  • Genetic Disorder
  • Others
• By Region
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East & Africa
  • GCC Countries
  • Israel
  • Rest of Middle East & Africa
• Key Players
  • Boston Biomedical Inc
  • Dicerna Pharmaceuticals Inc.
  • Marina Biotech Inc.
  • Propanac Biopharma Inc
  • Warp Drive Bio Inc.
  • prism pharma co ltd.,
  • aileron therapeutics inc.,
  • MD2 Biosciences Inc.,
  • WntRx Pharmaceuticals Inc.,
  • Sapience Therapeutics Inc.,
  • Venn Therapeutics LLC

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Type
  • Market Snapshot, By Application
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Product Approval
• Collaboration/Merge/Acquisition
• Regulatory Landscape
• PEST Analysis
• Porter's Five Forces Analysis
• Epidemiology
• Robust Pipeline Analysis

4. Global Beta Catenin Market, By Type, 2026 - 2033, (USD Mn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2026- 2033
  • Segment Trends
• BBI-801
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
• Exisulind
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
• M-101
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
• Nefopam Hydrochloride
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)

5. Global Beta Catenin Market, By Application, 2026 - 2033, (USD Mn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2026 - 2033
  • Segment Trends
• Dermatology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
• Oncology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
• Genetic Disorder
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)

6. Global Beta Catenin Market, By Region, 2026 - 2033, (USD Mn)

• Introduction
  • Market Share Analysis, By Region, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, For Regions, 2026-2033
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Mn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Mn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Mn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Mn)
    • GCC
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2026 - 2033, (USD Mn)
    • North Africa
    • Central Africa
    • South Africa

7. Competitive Landscape

• Heat Map Analysis
• Market Share Analysis
• Company Profile
  • Boston Biomedical Inc
• Company Highlights
• Product Portfolio
• Financial Performance
• Recent Highlights
• Market Strategies
  • Dicerna Pharmaceuticals Inc.
• Company Highlights
• Product Portfolio
• Financial Performance
• Recent Highlights
• Market Strategies
  • Marina Biotech Inc.
• Company Highlights
• Product Portfolio
• Financial Performance
• Recent Highlights
• Market Strategies
  • Propanac Biopharma Inc
• Company Highlights
• Product Portfolio
• Financial Performance
• Recent Highlights
• Market Strategies
  • Warp Drive Bio Inc.
• Company Highlights
• Product Portfolio
• Financial Performance
• Recent Highlights
• Market Strategies
  • prism pharma co ltd
• Company Highlights
• Product Portfolio
• Financial Performance
• Recent Highlights
• Market Strategies
  • aileron therapeutics inc
• Company Highlights
• Product Portfolio
• Financial Performance
• Recent Highlights
• Market Strategies
  • MD2 Biosciences Inc
• Company Highlights
• Product Portfolio
• Financial Performance
• Recent Highlights
• Market Strategies
  • WntRx Pharmaceuticals Inc
• Company Highlights
• Product Portfolio
• Financial Performance
• Recent Highlights
• Market Strategies
  • Sapience Therapeutics Inc
• Company Highlights
• Product Portfolio
• Financial Performance
• Recent Highlights
• Market Strategies
  • Venn Therapeutics LLC
• Company Highlights
• Product Portfolio
• Financial Performance
• Recent Highlights
• Market Strategies
• Analyst Views

8. Section

• References
• Research Methodology
• About Us